Fludarabine, Bortezomib, Myocet®and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma

Title
Fludarabine, Bortezomib, Myocet®and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 148, Issue 5, Pages 810-812
Publisher
Wiley
Online
2009-11-17
DOI
10.1111/j.1365-2141.2009.07998.x

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation